Effect of standard-dose Betahistine on endolymphatic hydrops: An MRI pilot study

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 4, 2013, Pages 1231-1235

  Gurkov R ^a   Flatz, W ^a   Keeser, D ^a   Strupp, M ^a   Ertl Wagner, B ^a   Krause, E ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Betahistine; Endolymphatic hydrops; Magnetic resonance imaging; Meni re's disease

Indexed keywords

BETAHISTINE; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FOLLOW UP; HUMAN; MENIERE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AGED; AUDIOMETRY, PURE-TONE; BETAHISTINE; COHORT STUDIES; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOLYMPHATIC HYDROPS; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MENIERE DISEASE; MIDDLE AGED; PILOT PROJECTS; RETROSPECTIVE STUDIES; VESTIBULAR EVOKED MYOGENIC POTENTIALS; VESTIBULE, LABYRINTH;

EID: 84877603787     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2087-3     Document Type: Article

References (21)

1. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. (1995) Otolaryngol Head Neck Surg 113:181-185
2. Merchant SN, Adams JC, Nadol JB Jr (2005) Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26:74-81
3. Kim HH, Wiet RJ, Battista RA (2005) Trends in the diagnosis and the management of Meniere's disease: results of a survey. Otolaryngol Head Neck Surg 132:722-726
4. Westhofen M (2009) Meniere's disease: evidence and controversies. HNO 57:446-454
5. Smith WK, Sankar V, Pfleiderer AG (2005) A national survey amongst UK otolaryngologists regarding the treatment of Meniere's disease. J Laryngol Otol 119:102-105
6. Timmerman H (1991) Histamine agonists and antagonists. Acta Otolaryngol Suppl 479:5-11
7. Arrang JM, Devaux B, Chodkiewicz JP et al (1988) H3-receptors control histamine release in human brain. J Neurochem 51:105-108
8. Martinez DM (1972) The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol Suppl 305:29-47
9. James AL, Burton MJ (2001) Betahistine for Meniere's disease or syndrome. Cochrane Database Syst Rev (1):CD001873
10. Nakashima T, Naganawa S, Sugiura M et al (2007) Visualization of endolymphatic hydrops in patients with Meniere's Disease. The Laryngoscope 117:415-420
11. Gurkov R, Flatz W, Louza J et al (2011) In vivo visualization of endolyphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol 268:1743-1748
12. Louza J, Flatz W, Krause E, Gürkov R (2012) Short-term audiologic effect of intratympanic gadolinium contrast agent application in patients with Meniere's disease. Am J Otolaryngol [Epub ahead of print]
13. Suzuki H, Teranishi M, Naganawa S et al (2011) Contrast-enhanced MRI of the inner ear after intratympanic injection of meglumine gadopentetate or gadodiamide hydrate. Acta Otolaryngol 131:130-135
14. Kato M, Teranishi M, Katayama N et al (2011) Association between endolymphatic hydrops as revealed by magnetic resonance imaging and caloric response. Otol Neurotol 32:1480-1485
15. Hornibrook J, Coates M, Goh A et al (2012) Magnetic resonance imaging for Meniere's disease: correlation with tone burst electrocochleography. J Laryngol Otol 126:136-141
16. Horii A, Osaki Y, Kitahara T et al (2011) Endolymphatic hydrops in Meniere's disease detected by MRI after intratympanic administration of gadolinium: comparison with sudden deafness. Acta Otolaryngol 131:602-609
17. Fang ZM, Chen X, Gu X, Liu Y, Zhang R, Cao DR, He HG (2012) A new magnetic resonance imaging scoring system for perilymphatic space appearance after intratympanic gadolinium injection, and its clinical application. J Laryngol Otol 126(5):454-459
18. Laurikainen E, Miller JM, Nuttall AL et al (1998) The vascular mechanism of action of betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol 255:119-123
19. Laurikainen E, Miller JF, Pyykko I (2000) Betahistine effects on cochlear blood flow: from the laboratory to the clinic. Acta Otolaryngol Suppl 544:5-7
20. Strupp M, Hupert D, Frenzel C (2008) Long-term prophylactic treatment of attacks of vertigo in Meniere's disease-comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 128:520-524
21. Lezius F, Adrion C, Mansmann U et al (2011) High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Meniere's disease: a case series. Eur Arch Otorhinolaryngol 268:1237-1240